Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Androgen Treatment in Leydig Cell Proliferation

NCT01206270 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT01206270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01206270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Androgen Treatment in Leydig Cell Proliferation
Lead sponsor
University of Roma La Sapienza
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2009
Completion date
June 30, 2018
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypergonadotropic azospermia, hypergonadotropic cryptozoospermia, hypergonadotropic hypogonadism, klinefelter syndrome